Prodromal manifestations of Parkinson's disease in adults with 22q11.2 microdeletion syndrome
Juri, C.; Chana, P. M.; Kramer, V.; Fritsch, R.; Ornstein, C.; Cuiza, A.; Hernandez, C.; Villanueva, K.; Cordova, T.; Mauro, J.; Ocampo, A.; Rebolledo-Jaramillo, B.; Encina, G.; Calleja, A.; Alcayaga, J. P.; Dinator, J.; Crossley, N.; Repetto, G. M.
Show abstract
22q11.2 microdeletion syndrome (22qDS) was recently identified as a risk factor for development of early-onset Parkinsons disease (PD). The classical motor manifestations of this disease are preceded by early signs and symptoms of neurodegeneration. The progression of 22qDS-associated PD is unknown. We aimed to evaluate the presence of prodromal PD in a group of adults with 22qDS using the Movement Disorders Society (MDS) Criteria for Prodromal PD. Thirty-eight persons with 22qDS and 13 age-matched controls participated in the study, and their results were compared using the Mann-Whitney U test. Persons with 22qDS had lower scores on olfaction testing (p=7.42Ex10-5), higher scores on the COMPASS 31 scale for dysautonomia (p=2.28x10-3) and on the motor evaluation using Movement Disorder Society (MDS)-sponsored revision of Unified Parkinsons Disease Rating Scale motor subscore (UPDRS-III) (p=1.84x10-4), compared with healthy controls. Home polysomnogram did not find participants with REM-sleep behavior disorder. Integrity of nigrostriatal dopaminergic system was evaluated by PET-CT imaging of presynaptic dopamine with 18F-PR04.MZ. Patients showed significantly higher specific binding ratios in the striatum, compared to controls (p=9.57x10-3 at the caudate nuclei). Two patients with 22qDS (5.2%) had decreased uptake in the posterior putamen (less than 60% of controls) and one fulfilled MDS criteria for prodromal PD. These results show that patients with 22qDS manifest some signs and symptoms of prodromal PD such as hyposmia, dysautonomia and mild movement alterations. In the majority, this was associated with elevated dopaminergic signaling, suggesting that loss of dopaminergic neurons may not be the cause. A smaller subgroup did show evidence of a decrease in nigrostriatal dopaminergic signaling, as seen in classical prodromal PD. Longitudinal studies are necessary to understand the progression to and risk of PD in persons with 22qDS.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- impaired bed mobility in prediagnostic and de novo Parkinson’s disease 94%
- Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study 94%
- MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson’s disease risk and age at onset 92%
Similar papers in this journal
- Severe GBA1 variants drive the GBA-PD clinical phenotype: implications for counselling and clinical trials 94%
- Nigral volume loss in prodromal, early, and moderate Parkinson’s disease 94%
- Longitudinal Assessment of DNA Repair Signature Trajectory in Prodromal versus Established Parkinsons Disease 94%
Similar papers in this journal
- Does COMT Play a Role in Parkinson's Disease Susceptibility Across Diverse Ancestral Populations? 94%
- The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians 94%
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression 93%
Similar papers in this journal
- Deep Brain Stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's Disease 96%
- Atrophy of the Nucleus Basalis of Meynert predicts the progression of gait variability in Parkinson's disease 91%
- Multi-omics dissection of Parkinson's patient subgroups associated with motor and cognitive severity 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.